目次

Chapter- 1: Foreword
Research Review Scope

Chapter- 2: Gene Editing Therapeutics Market (BIO259A)
Scope of Report of Gene Editing Therapeutics
Market Outlook of Gene Editing Therapeutics
Market Summary
Market Overview of Gene Editing Therapeutics
Genome-Editing Tool Types
Market Dynamics of Gene Editing Therapeutics
Emerging Technologies and Opportunities of Gene Editing Therapeutics
Base Editing
Prime Editing
Cas-Clover and Cas-FOKl
CRISPR Interference and CRISPR Activation
RNA Editing
Artificial Intelligence in Genome Editing
Market Analysis of Gene Editing Therapeutics
Market of Gene Editing Therapeutics by Region
ESG Performance in Gene Editing Therapeutics Market

Chapter- 3: Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)
Scope of Report of DNA Sequencing: Research, Applied and Clinical Markets
Market Outlook of DNA Sequencing: Research, Applied and Clinical Markets
Market Summary of DNA Sequencing: Research, Applied and Clinical Markets
Market Overview of DNA Sequencing: Research, Applied and Clinical Markets
Genetic Variation and Analysis
Research and Applied Applications
R&D Applications
Applied Applications
Market Dynamics of DNA Sequencing: Research, Applied and Clinical Markets
Emerging Technologies of DNA Sequencing: Research, Applied and Clinical Markets
Market Breakdown of DNA Sequencing: Research, Applied and Clinical Markets by Technology
Market Breakdown of DNA Sequencing: Research, Applied and Clinical Markets by Region
ESG Performance in DNA Sequencing Industry
ESG Risk Ratings in the DNA Sequencing Industry
Concluding Remarks from BCC Research

Chapter- 4: Next-generation Sequencing: Emerging Clinical Applications and Global Markets (BIO126E)
Scope of Report of Next-generation Sequencing
Market Outlook of Next-generation Sequencing
Market Summary of Next-generation Sequencing
Market Overview of Next-generation Sequencing
Liquid and Tissue Biopsy
Growth Drivers of Clinical NGS
Key Trends
Market Dynamics of Next-generation Sequencing
Emerging Technologies of Next-generation Sequencing
R&D Initiatives and Programs
Market Breakdown of Next-generation Sequencing by Disease Category
Market Breakdown of Next-generation Sequencing by Region
ESG Performance in Next-generation Sequencing Industry
Case Study
BCC Research Viewpoint

Chapter- 5: RNA Sequencing: Technologies and Global Markets (BIO147B)
Scope of Report of RNA Sequencing
Market Outlook of RNA Sequencing
Market Summary of RNA Sequencing
Market Overview of RNA Sequencing
Regulatory Landscape of RNA Sequencing
Growth Strategy Recommendations
Market Dynamics of RNA Sequencing
Emerging Technologies and Developments of RNA Sequencing Market
Market Breakdown of RNA Sequencing by Product
Market Breakdown of RNA Sequencing by Region
Sustainability in RNA Sequencing Market: ESG Perspective
ESG Practices in the RNA Sequencing Industry
Concluding Remarks from BCC Research

Chapter- 6: RNAi Technologies and Global Markets ( BIO127C)
Scope of Report of RNAi Technologies
Market Snapshot of RNAi Technologies
Market Summary of RNAi Technologies
Market Overview of RNAi Technologies
RNA Interference Overview
RNA Interference: Mechanism of Action
Market Dynamics of RNAi Technologies
Emerging Technologies and Opportunities of RNAi Technologies
Therapeutics
Diagnostics
Agriculture
Market for RNAi Technology by Technology
Market for RNAi Technology by Region
Sustainability in RNAi Technology Industry: An ESG Perspective
Case Study
Concluding Remarks from BCC

Chapter- 7: Viral Vector and Plasmid DNA: Technologies and Global Markets (BIO192B)
Scope of Report of Viral Vector and Plasmid DNA
Market Outlook of Viral Vector and Plasmid DNA
Market Summary of Viral Vector and Plasmid DNA
Market Overview of Viral Vector and Plasmid DNA
Market Dynamics of Viral Vector and Plasmid DNA
Emerging Technologies and Opportunities of Viral Vector and Plasmid DNA
Market for Viral Vector and Plasmid DNA Technologies by Product Type
Market for Viral Vector and Plasmid DNA Technologies by Application
Market for Viral Vector and Plasmid DNA Technologies by Region
Sustainability in the Market for Viral Vector and Plasmid DNA Technologies: An ESG Perspective
ESG Performance Among Major Companies
ESG Performance of Select Companies
Conclusion

Chapter- 8: Appendix
Methodology
Analyst's Credentials